Filana Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|
| – | -29.6% | -10.5% | -3.9% | -4.2% | -8.8% | -8.4% | -4.1% | |
| – | -32.6% | -12.0% | -4.4% | -5.1% | -10.3% | -10.0% | -4.8% | |
| – | -13.7% | -8.7% | -4.2% | -5.6% | -10.0% | -9.3% | -4.5% | |
| – | -13.7% | -8.7% | -4.2% | -5.6% | -10.0% | -9.3% | -4.5% | |
| – | -84.9% | -8.8% | -3.4% | -2.2% | -85.3% | -2.5% | – | |
| – | -46.4% | – | – | – | – | – | – | |
| – | -79.3% | +12.6% | +256.0% | +1.6% | -8.7% | -8.5% | +0.2% | |
| – | -79.4% | +12.7% | +257.6% | +1.5% | -8.8% | -8.5% | +0.1% | |
| – | -85.3% | +7.0% | +422.7% | +7.6% | -86.1% | +512.6% | +0.3% | |
| – | -12.6% | -12.4% | -31.1% | -7.3% | -8.8% | -8.4% | -6.7% | |
| – | – | – | – | – | – | – | – | |
| – | +9,925.6% | -99.0% | +0.1% | +0.0% | +0.0% | +0.0% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.